Skip to main navigation Skip to search Skip to main content

Nocardioazines : a novel bridged diketopiperazine scaffold from a marine-derived bacterium inhibits p-glycoprotein

  • Ritesh Raju
  • , Andrew Piggott
  • , Xiao-Cong Huang
  • , Robert Capon

Research output: Contribution to journalArticlepeer-review

123 Citations (Scopus)

Abstract

An Australian marine sediment-derived isolate, Nocardiopsis sp. (CMB-M0232), yielded a new class of prenylated diketopiperazine, indicative of the action of a uniquely regioselective diketopiperazine indole prenyltransferase. The bridged scaffold of nocardioazine A proved to be a noncytotoxic inhibitor of the membrane protein efflux pump P-glycoprotein, reversing doxorubicin resistance in a multidrug resistant colon cancer cell.
Original languageEnglish
Pages (from-to)2770-2773
Number of pages4
JournalOrganic Letters
Volume13
Issue number10
DOIs
Publication statusPublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Nocardioazines : a novel bridged diketopiperazine scaffold from a marine-derived bacterium inhibits p-glycoprotein'. Together they form a unique fingerprint.

Cite this